GLS and prostate carcinoma: found that prostate cancer cells have a high glutamine requirement, and inhibition of GLS to target glutamine metabolism in prostate cells resulted in significant radiosensitization of cancer cells,50, 51 suggesting that inhibition of glutamine metabolism can be used as a prognostic biomarker and therapeutic target for radiosensitization of prostate cancer.